Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 43.91 M49.47 M38.33 M33.66 M 165.37 M Research & development ———— — Operating income 251.69 M224.46 M226.39 M275.55 M 970.21 M Non-Operating Income, Total 1.4 M3.91 M153 K372 K 5.84 M Interest expense, net of interest capitalized 64.01 M64.07 M65.68 M64.14 M 257.89 M Non-Operating Income, excl. Interest Expenses -62.61 M-60.16 M-65.53 M-63.76 M -252.06 M Unusual income/expense ———— — Pretax income 181.21 M164.3 M160.86 M211.26 M 717.63 M Equity in earnings 49.9 M—0— — Taxes 45.33 M41.38 M43.34 M51.79 M 181.84 M Non-controlling/minority interest 65 K59 K49 K76 K 249 K After tax other income/expense ———— — Net income before discontinued operations 135.81 M122.86 M117.47 M159.4 M 535.54 M Discontinued operations ———— — Net income 135.81 M122.86 M117.47 M159.4 M 535.54 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 135.81 M122.86 M117.47 M159.4 M 535.54 M Basic earnings per share (Basic EPS) 0.980.870.841.13 3.82 Diluted earnings per share (Diluted EPS) 0.970.860.831.13 3.79 Average basic shares outstanding 139.03 M141.9 M140.32 M141.6 M — Diluted shares outstanding 139.93 M142.99 M141.42 M142.69 M — EBITDA 300.78 M278.06 M281.66 M332.96 M 1.19 B EBIT 238.22 M213.28 M211.88 M258.18 M 921.56 M Cost of revenue 810 M794.01 M792.55 M799.85 M 3.2 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 62.57 M64.77 M69.78 M74.78 M 271.9 M